PharmaCoNets of Amphetamine (SPCN: 33.24 )

Drug NamePathway IDPathway nameP-valueNo. of gene membersUniProt ACGene nameDetail of Coexpression
Amphetaminehsa00030Pentose phosphate pathway3.06E-043P60891, P51854, P37837PRPS1, TKTL1, TALDO1More
Amphetaminehsa00190Oxidative phosphorylation2.29E-022Q16718, O14521NDUFA5, SDHDMore
Amphetaminehsa00531Glycosaminoglycan degradation8.18E-042P15586, P34059GNS, GALNSMore
Amphetaminehsa00532Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate2.92E-021Q9Y2C2USTMore
Amphetaminehsa00604Glycosphingolipid biosynthesis - ganglio series2.87E-033P06865, O15466, Q9H4F1HEXA, ST8SIA5, ST6GALNAC4More
Amphetaminehsa00770Pantothenate and CoA biosynthesis1.15E-022O95498, Q9NRN7VNN2, AASDHPPTMore
Amphetaminehsa00830Retinol metabolism4.25E-021P00325ADH1BMore
Amphetaminehsa01200Carbon metabolism4.32E-023P51854, P37837, P60891TKTL1, TALDO1, PRPS1More
Amphetaminehsa01230Biosynthesis of amino acids2.60E-023P51854, P60891, P37837TKTL1, PRPS1, TALDO1More
Amphetaminehsa01240Biosynthesis of cofactors2.52E-022Q9BQB6, P14550VKORC1, AKR1A1More
Amphetaminehsa02010ABC transporters2.29E-022P45844, P08183ABCG1, ABCB1More
Amphetaminehsa03008Ribosome biogenesis in eukaryotes2.06E-022Q9NYH9, Q9BVP2UTP6, GNL3More
Amphetaminehsa03015mRNA surveillance pathway1.37E-036Q13362, Q14738, O94913, Q9UBU9, Q9H307, Q13148PPP2R5C, PPP2R5D, PCF11, NXF1, PNN, TARDBPMore
Amphetaminehsa03022Basal transcription factors3.32E-022O00268, Q15544TAF4, TAF11More
Amphetaminehsa03410Base excision repair2.52E-022P49005, P29372POLD2, MPGMore
Amphetaminehsa04020Calcium signaling pathway1.39E-024P30679, O15399, P07550, P23634GNA15, GRIN2D, ADRB2, ATP2B4More
Amphetaminehsa04071Sphingolipid signaling pathway8.46E-047P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2More
Amphetaminehsa04080Neuroactive ligand-receptor interaction1.97E-025P28472, P21453, Q9H228, P21730, P07550GABRB3, S1PR1, EDG8, C5AR1, ADRB2More
Amphetaminehsa04114Oocyte meiosis1.25E-037P51812, Q02750, P0DP23, P16298, Q17RY0, Q13362, Q14738RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, PPP2R5C, PPP2R5DMore
Amphetaminehsa04120Ubiquitin mediated proteolysis3.42E-036Q14145, Q13042, P30260, Q13191, P62837, Q15751KEAP1, CDC16, CDC27, CBLB, UBE2D2, HERC1More
Amphetaminehsa04142Lysosome1.14E-023P43234, P15586, P34059CTSO, GNS, GALNSMore
Amphetaminehsa04150mTOR signaling pathway3.60E-023Q02750, Q9NQL2, P51812MAP2K1, RRAGD, RPS6KA3More
Amphetaminehsa04152AMPK signaling pathway1.83E-023Q96RR4, Q13362, Q14738CAMKK2, PPP2R5C, PPP2R5DMore
Amphetaminehsa04210Apoptosis9.18E-034P04637, P24522, P43234, P63261TP53, GADD45A, CTSO, ACTG1More
Amphetaminehsa04217Necroptosis2.34E-024P01375, P48023, Q14765, Q99878TNF, FASLG, STAT4, H2AC14More
Amphetaminehsa04261Adrenergic signaling in cardiomyocytes3.75E-036P07550, P22694, P18848, Q13362, Q14738, P0DP23ADRB2, PRKACB, ATF4, PPP2R5C, PPP2R5D, CALM1More
Amphetaminehsa04340Hedgehog signaling pathway1.80E-024P49841, P22694, Q13635, P10415GSK3B, PRKACB, PTCH1, BCL2More
Amphetaminehsa04370VEGF signaling pathway2.68E-033P16298, Q05397, Q02750PPP3CB, PTK2, MAP2K1More
Amphetaminehsa04610Complement and coagulation cascades2.78E-031P0C0L4C4AMore
Amphetaminehsa04612Antigen processing and presentation1.07E-036Q14953, P26715, P26717, Q13241, P01732, P01375KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNFMore
Amphetaminehsa04613Neutrophil extracellular trap formation4.20E-025P04908, Q93077, P68431, O43315, Q16539H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14More
Amphetaminehsa04650Natural killer cell mediated cytotoxicity3.52E-0510P16298, P50591, P01375, P20963, Q02750, Q13241, P26718, P26717, Q14953, P26715PPP3CB, TNFSF10, TNF, CD247, MAP2K1, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1More
Amphetaminehsa04657IL-17 signaling pathway2.41E-024P19875, P14780, P80188, P01375CXCL2, MMP9, LCN2, TNFMore
Amphetaminehsa04668TNF signaling pathway3.55E-024P01375, P18848, P19875, P14780TNF, ATF4, CXCL2, MMP9More
Amphetaminehsa04714Thermogenesis5.21E-034Q16539, P33121, Q16718, O14521MAPK14, ACSL1, NDUFA5, SDHDMore
Amphetaminehsa04720Long-term potentiation1.38E-023P16298, P51812, Q02750PPP3CB, RPS6KA3, MAP2K1More
Amphetaminehsa04722Neurotrophin signaling pathway3.27E-023P49841, O43524, P48023GSK3B, FOXO3, FASLGMore
Amphetaminehsa04728Dopaminergic synapse2.66E-023Q13362, Q14738, P0DP23PPP2R5C, PPP2R5D, CALM1More
Amphetaminehsa04740Olfactory transduction2.52E-021Q9H255OR51E2More
Amphetaminehsa04742Taste transduction1.01E-021P30939HTR1FMore
Amphetaminehsa04913Ovarian steroidogenesis2.54E-022P42330, P22694AKR1C3, PRKACBMore
Amphetaminehsa04914Progesterone-mediated oocyte maturation2.94E-023Q17RY0, P51812, Q02750CPEB4, RPS6KA3, MAP2K1More
Amphetaminehsa04921Oxytocin signaling pathway3.13E-023P0DP23, Q96RR4, Q13469CALM1, CAMKK2, NFATC2More
Amphetaminehsa04924Renin secretion3.43E-033P22694, P07550, Q14643PRKACB, ADRB2, ITPR1More
Amphetaminehsa04926Relaxin signaling pathway2.41E-024P18848, P22694, P14780, P30679ATF4, PRKACB, MMP9, GNA15More
Amphetaminehsa04927Cortisol synthesis and secretion2.54E-022P18848, P22694ATF4, PRKACBMore
Amphetaminehsa04932Non-alcoholic fatty liver disease2.44E-035P01375, P49841, P48023, Q16718, O14521TNF, GSK3B, FASLG, NDUFA5, SDHDMore
Amphetaminehsa04940Type I diabetes mellitus1.87E-022P48023, P01375FASLG, TNFMore
Amphetaminehsa04966Collecting duct acid secretion1.68E-022P02730, P00918SLC4A1, CA2More
Amphetaminehsa04970Salivary secretion1.91E-023P07550, P22694, P49913ADRB2, PRKACB, CAMPMore
Amphetaminehsa04976Bile secretion3.32E-022O43315, P08183AQP9, ABCB1More
Amphetaminehsa04979Cholesterol metabolism1.61E-022P38571, P61916LIPA, NPC2More
Amphetaminehsa05020Prion disease3.80E-024Q16718, O14521, P49841, Q16539NDUFA5, SDHD, GSK3B, MAPK14More
Amphetaminehsa05022Pathways of neurodegeneration - multiple diseases1.24E-026P49841, Q16718, O14521, Q13561, Q16539, Q08752GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPIDMore
Amphetaminehsa05031Amphetamine addiction4.32E-023P22694, P18848, Q13547PRKACB, ATF4, HDAC1More
Amphetaminehsa05033Nicotine addiction1.22E-022P28472, O15399GABRB3, GRIN2DMore
Amphetaminehsa05133Pertussis4.94E-021P0C0L4C4AMore
Amphetaminehsa05143African trypanosomiasis2.72E-022P01375, P48023TNF, FASLGMore
Amphetaminehsa05144Malaria3.02E-034O60603, P01375, P35443, P26718TLR2, TNF, THBS4, KLRK1More
Amphetaminehsa05146Amoebiasis2.41E-024P19875, P01375, P30679, P22694CXCL2, TNF, GNA15, PRKACBMore
Amphetaminehsa05160Hepatitis C1.27E-024P60033, P49841, P01375, P48023CD81, GSK3B, TNF, FASLGMore
Amphetaminehsa05167Kaposi sarcoma-associated herpesvirus infection2.39E-037P23458, P62879, Q13469, P16298, Q02750, P0DP23, P0CG47JAK1, GNB2, NFATC2, PPP3CB, MAP2K1, CALM1, UBBMore
Amphetaminehsa05170Human immunodeficiency virus 1 infection6.02E-035Q02750, P62879, P16298, Q05397, P20333MAP2K1, GNB2, PPP3CB, PTK2, TNFRSF1BMore
Amphetaminehsa05205Proteoglycans in cancer4.79E-038P63261, P04637, P14780, P01375, P23588, Q06124, Q13635, P22694ACTG1, TP53, MMP9, TNF, EIF4B, PTPN11, PTCH1, PRKACBMore
Amphetaminehsa05211Renal cell carcinoma7.75E-032Q06124, Q99814PTPN11, EPAS1More
Amphetaminehsa05212Pancreatic cancer2.33E-034Q15311, P23458, P04637, P24522RALBP1, JAK1, TP53, GADD45AMore
Amphetaminehsa05213Endometrial cancer2.44E-034O15169, Q02750, P04637, P24522AXIN1, MAP2K1, TP53, GADD45AMore
Amphetaminehsa05214Glioma2.60E-022P04637, P24522TP53, GADD45AMore
Amphetaminehsa05216Thyroid cancer1.14E-022P04637, P24522TP53, GADD45AMore
Amphetaminehsa05217Basal cell carcinoma2.06E-022P04637, P24522TP53, GADD45AMore
Amphetaminehsa05218Melanoma3.41E-045P09619, Q9GZP0, P04637, Q02750, P24522PDGFRB, PDGFD, TP53, MAP2K1, GADD45AMore
Amphetaminehsa05220Chronic myeloid leukemia7.90E-033Q06124, P04637, P24522PTPN11, TP53, GADD45AMore
Amphetaminehsa05223Non-small cell lung cancer3.19E-022P04637, P24522TP53, GADD45AMore
Amphetaminehsa05224Breast cancer4.51E-022P04637, P24522TP53, GADD45AMore
Amphetaminehsa05225Hepatocellular carcinoma3.30E-023P04637, P24522, P63261TP53, GADD45A, ACTG1More
Amphetaminehsa05226Gastric cancer3.79E-022Q02750, O15169MAP2K1, AXIN1More
Amphetaminehsa05231Choline metabolism in cancer9.39E-034Q02750, P09619, Q9GZP0, O15245MAP2K1, PDGFRB, PDGFD, SLC22A1More
Amphetaminehsa05321Inflammatory bowel disease3.02E-034O60603, P01375, Q14765, Q9UL17TLR2, TNF, STAT4, TBX21More
Amphetaminehsa05330Allograft rejection2.72E-022P48023, P01375FASLG, TNFMore
Amphetaminehsa05332Graft-versus-host disease5.46E-055P48023, P10747, P01375, P26715, Q13241FASLG, CD28, TNF, KLRC1, KLRD1More
Amphetaminehsa05412Arrhythmogenic right ventricular cardiomyopathy3.10E-023Q8IZS8, P54284, P13612CACNA2D3, CACNB3, ITGA4More
Amphetaminehsa05414Dilated cardiomyopathy2.11E-024Q8IZS8, P54284, P13612, P26678CACNA2D3, CACNB3, ITGA4, PLNMore
Amphetaminehsa05415Diabetic cardiomyopathy1.28E-024Q16718, O14521, Q16539, P49841NDUFA5, SDHD, MAPK14, GSK3BMore
Dextroamphetaminehsa00030Pentose phosphate pathway3.06E-043P60891, P51854, P37837PRPS1, TKTL1, TALDO1More
Dextroamphetaminehsa00190Oxidative phosphorylation2.29E-022Q16718, O14521NDUFA5, SDHDMore
Dextroamphetaminehsa00531Glycosaminoglycan degradation8.18E-042P15586, P34059GNS, GALNSMore
Dextroamphetaminehsa00532Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate2.92E-021Q9Y2C2USTMore
Dextroamphetaminehsa00604Glycosphingolipid biosynthesis - ganglio series2.87E-033P06865, O15466, Q9H4F1HEXA, ST8SIA5, ST6GALNAC4More
Dextroamphetaminehsa00770Pantothenate and CoA biosynthesis1.15E-022O95498, Q9NRN7VNN2, AASDHPPTMore
Dextroamphetaminehsa00830Retinol metabolism4.25E-021P00325ADH1BMore
Dextroamphetaminehsa01200Carbon metabolism4.32E-023P51854, P37837, P60891TKTL1, TALDO1, PRPS1More
Dextroamphetaminehsa01230Biosynthesis of amino acids2.60E-023P51854, P60891, P37837TKTL1, PRPS1, TALDO1More
Dextroamphetaminehsa01240Biosynthesis of cofactors2.52E-022Q9BQB6, P14550VKORC1, AKR1A1More
Dextroamphetaminehsa02010ABC transporters2.29E-022P45844, P08183ABCG1, ABCB1More
Dextroamphetaminehsa03008Ribosome biogenesis in eukaryotes2.06E-022Q9NYH9, Q9BVP2UTP6, GNL3More
Dextroamphetaminehsa03015mRNA surveillance pathway1.37E-036Q13362, Q14738, O94913, Q9UBU9, Q9H307, Q13148PPP2R5C, PPP2R5D, PCF11, NXF1, PNN, TARDBPMore
Dextroamphetaminehsa03022Basal transcription factors3.32E-022O00268, Q15544TAF4, TAF11More
Dextroamphetaminehsa03410Base excision repair2.52E-022P49005, P29372POLD2, MPGMore
Dextroamphetaminehsa04020Calcium signaling pathway1.39E-024P30679, O15399, P07550, P23634GNA15, GRIN2D, ADRB2, ATP2B4More
Dextroamphetaminehsa04071Sphingolipid signaling pathway8.46E-047P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2More
Dextroamphetaminehsa04080Neuroactive ligand-receptor interaction1.97E-025P28472, P21453, Q9H228, P21730, P07550GABRB3, S1PR1, EDG8, C5AR1, ADRB2More
Dextroamphetaminehsa04114Oocyte meiosis1.25E-037P51812, Q02750, P0DP23, P16298, Q17RY0, Q13362, Q14738RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, PPP2R5C, PPP2R5DMore
Dextroamphetaminehsa04120Ubiquitin mediated proteolysis3.42E-036Q14145, Q13042, P30260, Q13191, P62837, Q15751KEAP1, CDC16, CDC27, CBLB, UBE2D2, HERC1More
Dextroamphetaminehsa04142Lysosome1.14E-023P43234, P15586, P34059CTSO, GNS, GALNSMore
Dextroamphetaminehsa04150mTOR signaling pathway3.60E-023Q02750, Q9NQL2, P51812MAP2K1, RRAGD, RPS6KA3More
Dextroamphetaminehsa04152AMPK signaling pathway1.83E-023Q96RR4, Q13362, Q14738CAMKK2, PPP2R5C, PPP2R5DMore
Dextroamphetaminehsa04210Apoptosis9.18E-034P04637, P24522, P43234, P63261TP53, GADD45A, CTSO, ACTG1More
Dextroamphetaminehsa04217Necroptosis2.34E-024P01375, P48023, Q14765, Q99878TNF, FASLG, STAT4, H2AC14More
Dextroamphetaminehsa04261Adrenergic signaling in cardiomyocytes3.75E-036P07550, P22694, P18848, Q13362, Q14738, P0DP23ADRB2, PRKACB, ATF4, PPP2R5C, PPP2R5D, CALM1More
Dextroamphetaminehsa04340Hedgehog signaling pathway1.80E-024P49841, P22694, Q13635, P10415GSK3B, PRKACB, PTCH1, BCL2More
Dextroamphetaminehsa04370VEGF signaling pathway2.68E-033P16298, Q05397, Q02750PPP3CB, PTK2, MAP2K1More
Dextroamphetaminehsa04610Complement and coagulation cascades2.78E-031P0C0L4C4AMore
Dextroamphetaminehsa04612Antigen processing and presentation1.07E-036Q14953, P26715, P26717, Q13241, P01732, P01375KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNFMore
Dextroamphetaminehsa04613Neutrophil extracellular trap formation4.20E-025P04908, Q93077, P68431, O43315, Q16539H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14More
Dextroamphetaminehsa04650Natural killer cell mediated cytotoxicity3.52E-0510P16298, P50591, P01375, P20963, Q02750, Q13241, P26718, P26717, Q14953, P26715PPP3CB, TNFSF10, TNF, CD247, MAP2K1, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1More
Dextroamphetaminehsa04657IL-17 signaling pathway2.41E-024P19875, P14780, P80188, P01375CXCL2, MMP9, LCN2, TNFMore
Dextroamphetaminehsa04668TNF signaling pathway3.55E-024P01375, P18848, P19875, P14780TNF, ATF4, CXCL2, MMP9More
Dextroamphetaminehsa04714Thermogenesis5.21E-034Q16539, P33121, Q16718, O14521MAPK14, ACSL1, NDUFA5, SDHDMore
Dextroamphetaminehsa04720Long-term potentiation1.38E-023P16298, P51812, Q02750PPP3CB, RPS6KA3, MAP2K1More
Dextroamphetaminehsa04722Neurotrophin signaling pathway3.27E-023P49841, O43524, P48023GSK3B, FOXO3, FASLGMore
Dextroamphetaminehsa04728Dopaminergic synapse2.66E-023Q13362, Q14738, P0DP23PPP2R5C, PPP2R5D, CALM1More
Dextroamphetaminehsa04740Olfactory transduction2.52E-021Q9H255OR51E2More
Dextroamphetaminehsa04742Taste transduction1.01E-021P30939HTR1FMore
Dextroamphetaminehsa04913Ovarian steroidogenesis2.54E-022P42330, P22694AKR1C3, PRKACBMore
Dextroamphetaminehsa04914Progesterone-mediated oocyte maturation2.94E-023Q17RY0, P51812, Q02750CPEB4, RPS6KA3, MAP2K1More
Dextroamphetaminehsa04921Oxytocin signaling pathway3.13E-023P0DP23, Q96RR4, Q13469CALM1, CAMKK2, NFATC2More
Dextroamphetaminehsa04924Renin secretion3.43E-033P22694, P07550, Q14643PRKACB, ADRB2, ITPR1More
Dextroamphetaminehsa04926Relaxin signaling pathway2.41E-024P18848, P22694, P14780, P30679ATF4, PRKACB, MMP9, GNA15More
Dextroamphetaminehsa04927Cortisol synthesis and secretion2.54E-022P18848, P22694ATF4, PRKACBMore
Dextroamphetaminehsa04932Non-alcoholic fatty liver disease2.44E-035P01375, P49841, P48023, Q16718, O14521TNF, GSK3B, FASLG, NDUFA5, SDHDMore
Dextroamphetaminehsa04940Type I diabetes mellitus1.87E-022P48023, P01375FASLG, TNFMore
Dextroamphetaminehsa04966Collecting duct acid secretion1.68E-022P02730, P00918SLC4A1, CA2More
Dextroamphetaminehsa04970Salivary secretion1.91E-023P07550, P22694, P49913ADRB2, PRKACB, CAMPMore
Dextroamphetaminehsa04976Bile secretion3.32E-022O43315, P08183AQP9, ABCB1More
Dextroamphetaminehsa04979Cholesterol metabolism1.61E-022P38571, P61916LIPA, NPC2More
Dextroamphetaminehsa05020Prion disease3.80E-024Q16718, O14521, P49841, Q16539NDUFA5, SDHD, GSK3B, MAPK14More
Dextroamphetaminehsa05022Pathways of neurodegeneration - multiple diseases1.24E-026P49841, Q16718, O14521, Q13561, Q16539, Q08752GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPIDMore
Dextroamphetaminehsa05031Amphetamine addiction4.32E-023P22694, P18848, Q13547PRKACB, ATF4, HDAC1More
Dextroamphetaminehsa05033Nicotine addiction1.22E-022P28472, O15399GABRB3, GRIN2DMore
Dextroamphetaminehsa05133Pertussis4.94E-021P0C0L4C4AMore
Dextroamphetaminehsa05143African trypanosomiasis2.72E-022P01375, P48023TNF, FASLGMore
Dextroamphetaminehsa05144Malaria3.02E-034O60603, P01375, P35443, P26718TLR2, TNF, THBS4, KLRK1More
Dextroamphetaminehsa05146Amoebiasis2.41E-024P19875, P01375, P30679, P22694CXCL2, TNF, GNA15, PRKACBMore
Dextroamphetaminehsa05160Hepatitis C1.27E-024P60033, P49841, P01375, P48023CD81, GSK3B, TNF, FASLGMore
Dextroamphetaminehsa05167Kaposi sarcoma-associated herpesvirus infection2.39E-037P23458, P62879, Q13469, P16298, Q02750, P0DP23, P0CG47JAK1, GNB2, NFATC2, PPP3CB, MAP2K1, CALM1, UBBMore
Dextroamphetaminehsa05170Human immunodeficiency virus 1 infection6.02E-035Q02750, P62879, P16298, Q05397, P20333MAP2K1, GNB2, PPP3CB, PTK2, TNFRSF1BMore
Dextroamphetaminehsa05205Proteoglycans in cancer4.79E-038P63261, P04637, P14780, P01375, P23588, Q06124, Q13635, P22694ACTG1, TP53, MMP9, TNF, EIF4B, PTPN11, PTCH1, PRKACBMore
Dextroamphetaminehsa05211Renal cell carcinoma7.75E-032Q06124, Q99814PTPN11, EPAS1More
Dextroamphetaminehsa05212Pancreatic cancer2.33E-034Q15311, P23458, P04637, P24522RALBP1, JAK1, TP53, GADD45AMore
Dextroamphetaminehsa05213Endometrial cancer2.44E-034O15169, Q02750, P04637, P24522AXIN1, MAP2K1, TP53, GADD45AMore
Dextroamphetaminehsa05214Glioma2.60E-022P04637, P24522TP53, GADD45AMore
Dextroamphetaminehsa05216Thyroid cancer1.14E-022P04637, P24522TP53, GADD45AMore
Dextroamphetaminehsa05217Basal cell carcinoma2.06E-022P04637, P24522TP53, GADD45AMore
Dextroamphetaminehsa05218Melanoma3.41E-045P09619, Q9GZP0, P04637, Q02750, P24522PDGFRB, PDGFD, TP53, MAP2K1, GADD45AMore
Dextroamphetaminehsa05220Chronic myeloid leukemia7.90E-033Q06124, P04637, P24522PTPN11, TP53, GADD45AMore
Dextroamphetaminehsa05223Non-small cell lung cancer3.19E-022P04637, P24522TP53, GADD45AMore
Dextroamphetaminehsa05224Breast cancer4.51E-022P04637, P24522TP53, GADD45AMore
Dextroamphetaminehsa05225Hepatocellular carcinoma3.30E-023P04637, P24522, P63261TP53, GADD45A, ACTG1More
Dextroamphetaminehsa05226Gastric cancer3.79E-022Q02750, O15169MAP2K1, AXIN1More
Dextroamphetaminehsa05231Choline metabolism in cancer9.39E-034Q02750, P09619, Q9GZP0, O15245MAP2K1, PDGFRB, PDGFD, SLC22A1More
Dextroamphetaminehsa05321Inflammatory bowel disease3.02E-034O60603, P01375, Q14765, Q9UL17TLR2, TNF, STAT4, TBX21More
Dextroamphetaminehsa05330Allograft rejection2.72E-022P48023, P01375FASLG, TNFMore
Dextroamphetaminehsa05332Graft-versus-host disease5.46E-055P48023, P10747, P01375, P26715, Q13241FASLG, CD28, TNF, KLRC1, KLRD1More
Dextroamphetaminehsa05412Arrhythmogenic right ventricular cardiomyopathy3.10E-023Q8IZS8, P54284, P13612CACNA2D3, CACNB3, ITGA4More
Dextroamphetaminehsa05414Dilated cardiomyopathy2.11E-024Q8IZS8, P54284, P13612, P26678CACNA2D3, CACNB3, ITGA4, PLNMore
Dextroamphetaminehsa05415Diabetic cardiomyopathy1.28E-024Q16718, O14521, Q16539, P49841NDUFA5, SDHD, MAPK14, GSK3BMore

Community members of Amphetamine (SDC: 3.39)

UniProtACGene NameProtein NameReported/
Predicted
DisGeNETSPVSdrugabilitySHiSBiNSDisG
P07550ADRB2BetaNone2 adrenergic receptorReported00.007110.22052.224
P14416DRD2D(2) dopamine receptorReported00.060410.47792.5081
P31645SLC6A4SodiumNonedependent serotonin transporterReported00.047710.02032.0442
Q9Y4K0LOXL2Lysyl oxidase homolog 2Predicted00.02690.119800.253
P30679GNA15Guanine nucleotideNonebinding protein subunit alphaNone15Predicted00.03730.11460.28910.5369
P15144ANPEPAminopeptidase NPredicted10.18750.23650.29340.8601
P11511CYP19A1AromatasePredicted00.815610.15882.5666
Q9Y2I1NISCHNischarinPredicted10.60820.225100.7543
P30531SLC6A1SodiumNone and chlorideNonedependent GABA transporter 1Predicted10.08890.52020.10471.1894
P48029SLC6A8SodiumNone and chlorideNonedependent creatine transporter 1Predicted10.21610.232800.5737
P30939HTR1F5Nonehydroxytryptamine receptor 1FPredicted00.000910.01982.0202
This pair is Reported in Drugbank.
Gene nameUniProt_IDBioactivityValue (nM)
ADRB2P07550Ki>10000
DRD2P14416Ki>10000